The p53 gene is mutated in approximately 10-20% of primary and up to 42% of advanced PCa.[6][7][8] Among other TSGs, PTEN mutations are detected in up to 27% of localized and up to 60% of metastatic tumors.[9][10][11]. Here, TP53 is linked to posterior cortical atrophy.